Share
2,089 Posts.
lightbulb Created with Sketch. 1487
clock Created with Sketch. 19/01/24
12:15
Share
Originally posted by kpax:
↑
When looking at a biotech company with plenty of promise, Atlas Funds Management says one of the signposts it looks for is how close the company’s drugs are to an FDA approval.
Expand
Somebody needs to let Eddie know that one of the major FDA signposts he overlooked in this article is the ODD for monepantel that PAA are expecting from the FDA in Q1. Would've thought that would be covered as a major trigger for Aussie biotech investors to get excited, as per the theme of the article!
(20min delay)